Fund shareholders of Polaryx Therapeutics Inc
ISIN US73110F1003 · United States
- Fund shareholders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 12.5M $
- Share of capital
- 3.3 % of 49.8M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,468,014 | 11.1M $ | 0.00 % | 2.95 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 142,549 | 1.1M $ | 0.00 % | 0.29 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 25,969 | 196.3K $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 21,856 | 165.2K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Institutional managers
11 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 170,673 | 1.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 127,525 | 964.1K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 58,104 | 439.3K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 41,012 | 310.1K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 27,987 | 211.6K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 25,881 | 195.7K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 13,483 | 101.9K $ | as of Mar 31, 2026 |
| UBS Group AG | 13,479 | 101.9K $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 12,406 | 93.8K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 5,543 | 41.9K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,781 | 13.5K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Polaryx Therapeutics Inc". https://titelia.com/en/stocks/polaryx-therapeutics-inc-US73110F1003